PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery

This study has been completed.

Study NCT00365053 Information provided by National Cancer Institute (NCI)

First Received: August 16, 2006 Last Updated: April 14, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	March 2009 (Final data collection date for primary outcome measure)